BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7542066)

  • 21. Characterisation of immune mediator release during the immediate response to segmental mucosal challenge in the jejunum of patients with food allergy.
    Santos J; Bayarri C; Saperas E; Nogueiras C; Antolín M; Mourelle M; Cadahia A; Malagelada JR
    Gut; 1999 Oct; 45(4):553-8. PubMed ID: 10486364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators.
    Sedgwick JB; Calhoun WJ; Gleich GJ; Kita H; Abrams JS; Schwartz LB; Volovitz B; Ben-Yaakov M; Busse WW
    Am Rev Respir Dis; 1991 Dec; 144(6):1274-81. PubMed ID: 1741538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma.
    Sladek K; Szczeklik A
    Eur Respir J; 1993 Mar; 6(3):391-9. PubMed ID: 8386106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum eosinophil cationic protein, myeloperoxidase, tryptase, eotaxin and Th2-L-like cytokines in Dermatitis herpetiformis.
    Caproni M; Cardinali C; D'Agata A; Selvaggi W; Fabbri P
    Int Arch Allergy Immunol; 2002 May; 128(1):67-72. PubMed ID: 12037403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of human mast cell tryptase and eosinophil granule proteins on the kinetics of blood clotting.
    Samoszuk M; Corwin M; Hazen SL
    Am J Hematol; 2003 May; 73(1):18-25. PubMed ID: 12701115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Usefulness of measurement of mast cell tryptase for differential diagnosis of anaphylaxis and anaphylactoid reaction].
    Saitoh J; Mitsuhata H; Horiguchi Y; Saitoh K; Fukuda H; Shimizu R
    Masui; 1995 Sep; 44(9):1265-8. PubMed ID: 8523664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls.
    de Graaf-in t Veld C; Garrelds IM; Koenders S; Gerth van Wijk R
    Clin Exp Allergy; 1996 Aug; 26(8):903-8. PubMed ID: 8877155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum tryptase levels in adverse drug reactions.
    Ordoqui E; Zubeldia JM; Aranzábal A; Rubio M; Herrero T; Tornero P; Rodríguez VM; Prieto A; Baeza ML
    Allergy; 1997 Nov; 52(11):1102-5. PubMed ID: 9404562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tryptase: a clinical indicator of mast cell-dependent events.
    Schwartz LB
    Allergy Proc; 1994; 15(3):119-23. PubMed ID: 7926709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mast cells and tryptase in the middle ear of children with otitis media with effusion.
    Hurst DS; Amin K; Sevéus L; Venge P
    Int J Pediatr Otorhinolaryngol; 1999 Oct; 49 Suppl 1():S315-9. PubMed ID: 10577829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1.
    Lee YM; Kim SS; Kim HA; Suh YJ; Lee SK; Nahm DH; Park HS
    J Korean Med Sci; 2003 Feb; 18(1):97-102. PubMed ID: 12589095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Markers of airway inflammation in preschool wheezers.
    Carlsen KH
    Monaldi Arch Chest Dis; 1997 Oct; 52(5):455-60. PubMed ID: 9510666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity.
    Ferdousi HA; Dreborg S
    Clin Exp Allergy; 1997 May; 27(5):530-9. PubMed ID: 9179427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Levels of interleukin-4, interleukin-5, tryptase and eosinophil cationic protein of nasal lavage fluid in pollen allergic rhinitis].
    Rapp J; Kósa L; Halász A; Kereki E; Börzsönyi L
    Orv Hetil; 2000 Aug; 141(35):1919-22. PubMed ID: 11019593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitrogen dioxide increases eosinophil activation in the early-phase response to nasal allergen provocation.
    Wang JH; Duddle J; Devalia JL; Davies RJ
    Int Arch Allergy Immunol; 1995; 107(1-3):103-5. PubMed ID: 7613114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of mast cell activity in the middle ears of children with otitis media with effusion.
    Hurst DS; Amin K; Sevéus L; Venge P
    Laryngoscope; 1999 Mar; 109(3):471-7. PubMed ID: 10089978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mode of action of a topical steroid on immediate phase reaction after antigen challenge and nonspecific nasal hyperreactivity in nasal allergy.
    Konno A; Yamakoshi T; Terada N; Fujita Y
    Int Arch Allergy Immunol; 1994; 103(1):79-87. PubMed ID: 8260854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated serum tryptase levels in a patient with protracted anaphylaxis.
    Vinuya RZ; Simon MR; Schwartz LB
    Ann Allergy; 1994 Sep; 73(3):232-4. PubMed ID: 8092557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dynamic diagnosis of allergy by the sequential measurement of mediators: apropos of a case of food allergy].
    Sabbah A; Hassoun S; Drouet M; Lauret MG
    Allerg Immunol (Paris); 1994 Jan; 26(1):2-5. PubMed ID: 8166938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotype of cells positive for interleukin-4 and interleukin-5 mRNA in allergic tissue reactions.
    Kay AB; Ying S; Durham SR
    Int Arch Allergy Immunol; 1995; 107(1-3):208-10. PubMed ID: 7613132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.